A 2026 study published in JCI Insight by researchers at National Jewish Health found that short-term exposure to e-cigarette vapor damages the delicate tissue of the distal (deep) lung within 24 hours. The damage included disruption of the lung's protective barrier, cellular stress, impaired autophagy (the cell's cleanup process), slowed tissue repair, and increased cell death. After just 5 days of exposure, signs of lung stress persisted for 10 days after exposure ended, and the lungs showed weakened antiviral immune responses, including increased SARS-CoV-2 viral load in infection experiments.

The study was published in JCI Insight, a respected peer-reviewed journal, and was led by researchers at National Jewish Health, a leading respiratory research institution. However, it has important limitations: the experiments were conducted in laboratory-grown human lung cells, precision-cut lung tissue slices, and golden Syrian hamsters — not in living human vapers. Laboratory conditions can show biological mechanisms but cannot directly prove that the same effects occur at the same severity in real-world vapers. The findings need to be confirmed in human studies. The evidence level for this study is moderate — mechanistically strong but clinically unconfirmed.

The long-term question of permanent lung damage from vaping is still not fully answered. This new study found that some molecular changes persisted 10 days after a 5-day exposure period in hamsters, but persistent molecular changes don't necessarily equal permanent damage or disease. The researchers themselves noted that 'persistent molecular changes over days also do not, by themselves, prove permanent lung damage or a particular future disease.' Other research has shown that switching from smoking to vaping can improve lung function in former smokers. More long-term human studies are needed to determine whether vaping causes lasting lung damage.

No — the overwhelming consensus of public health research is that vaping is substantially less harmful than smoking for lung health and overall health. Public Health England estimates vaping is approximately 95% less harmful than smoking. Combustible cigarettes produce thousands of toxic chemicals from burning tobacco, including tar, carbon monoxide, and dozens of proven carcinogens. Vaping produces an aerosol with far fewer and lower levels of harmful constituents. However, 'less harmful than smoking' is not the same as 'safe.' This new study adds to evidence that vaping is not risk-free and may cause measurable lung effects. For a detailed comparison, see our full vaping vs smoking health analysis.

Autophagy is the body's cellular 'cleanup and recycling' process, where cells break down and remove damaged components. It's essential for keeping cells healthy and maintaining tissue function. The JCI Insight study found that e-cigarette vapor exposure disrupted the completion of autophagy in lung cells — essentially clogging the cleanup process. This disruption helps explain why vapor exposure causes cellular stress and tissue damage: when cells can't properly clear damaged material, it accumulates and contributes to injury. Impaired autophagy has also been linked to aging, neurodegenerative diseases, and reduced ability to fight infections.

This study suggests it might. Researchers found that prior vapor exposure increased SARS-CoV-2 (COVID-19) viral burden in lung tissue models and suppressed several antiviral genes. This adds to a growing body of research suggesting that vaping may impair respiratory immune defenses. However, it's important to note that this was in laboratory models, and real-world epidemiological data on vaping and respiratory infection risk has been mixed. Some population studies have found associations between vaping and increased respiratory infection risk, while others have not. More research is needed to confirm whether these lab findings translate to increased infection risk in actual vapers.

Nicotine-free vapes eliminate the risks associated with nicotine (addiction, cardiovascular effects, etc.) but may still carry lung risks from other components. The base of e-liquid — propylene glycol (PG) and vegetable glycerin (VG) — along with flavorings, are what produce the aerosol. A separate 2026 study published in BMC Pulmonary Medicine found that even nicotine-free vaping impaired airway cilia function and epithelial barrier integrity after repeated exposures. However, removing nicotine does reduce the overall risk profile. Our vape juice ingredients guide covers each component's safety profile in detail.

If you're a non-smoker who started vaping recreationally, the evidence increasingly supports quitting — vaping is not risk-free, and the long-term effects are still unknown. If you're a current smoker using vaping to stay off cigarettes, the picture is more nuanced: this study adds to evidence that vaping has biological effects on lung cells, but smoking is substantially more harmful. The key question is whether you'd return to smoking if you quit vaping. If you're considering quitting, talk to a healthcare provider about FDA-approved cessation methods. If you're a smoker who has successfully switched to vaping, consult a professional before making changes that might lead you back to smoking.

The respiratory system has different regions, and vaping affects them differently. The upper airways (mouth, throat, trachea, large bronchi) are where the aerosol first hits and are more commonly associated with throat irritation and cough. The distal lung — the deep lung tissue including small airways, alveoli, and the blood-gas barrier where oxygen enters the bloodstream — is far more delicate and functionally critical. This study is significant because it specifically looked at distal lung tissue and found damage there, which is more concerning than upper airway effects. The distal lung is where conditions like COPD, pneumonia, and ARDS do their most serious damage.

This study adds to a growing body of evidence that vaping is not harmless but is less harmful than smoking. It aligns with other recent studies: a 2026 Frontiers in Immunology study found vaping induces pro-inflammatory state in the lung; a 2026 BMC Pulmonary Medicine study found nicotine-free vaping impairs airway cilia function; and population studies have linked vaping to increased respiratory symptoms. However, it's important to balance these findings with research showing that switching from smoking to vaping improves lung function and reduces exposure to harmful chemicals by 90%+. The overall scientific consensus remains: vaping is reduced harm, not zero harm.